ID
21472
Description
A Study of Bortezomib, Cyclophosphamide, and Dexamethasone in Patients With Untreated Multiple Myeloma and Planned for a High Dose Chemotherapy; ODM derived from: https://clinicaltrials.gov/show/NCT00833560
Link
https://clinicaltrials.gov/show/NCT00833560
Keywords
Versions (1)
- 4/23/17 4/23/17 -
Uploaded on
April 23, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Multiple Myeloma DRKS00003762 NCT00833560
Eligibility Multiple Myeloma NCT00833560
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Non-secretory multiple myeloma
Data type
boolean
Alias
- UMLS CUI [1]
- C0456845
Description
Life expectancy
Data type
boolean
Alias
- UMLS CUI [1]
- C0023671
Description
Prior malignancy
Data type
boolean
Alias
- UMLS CUI [1]
- C2735088
Description
Neuropathy grade
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0442874
- UMLS CUI [1,2]
- C0441800
Description
HIV, HBV, HCV
Data type
boolean
Alias
- UMLS CUI [1]
- C0019699
- UMLS CUI [2]
- C0149709
- UMLS CUI [3]
- C1112419
Description
Gynaecological status
Data type
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C0006147
Similar models
Eligibility Multiple Myeloma NCT00833560
- StudyEvent: Eligibility
C1300072 (UMLS CUI [1,2])
C0441800 (UMLS CUI [1,2])
C0149709 (UMLS CUI [2])
C1112419 (UMLS CUI [3])
C0006147 (UMLS CUI [2])